December 8, 2022
FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits
Editor's Note
The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious.
The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19.
The recall was initiated because the kits were distributed to US customers without authorization, clearance, or approval by the FDA.
Distribution dates were May 2020 to January 2022.
Free Daily News
- FBI investigates as Oracle health data breach exposes patient information
- Study: Pulse oximeters may misestimate oxygen saturation in darker skin tones
- FDA issues Class 1 recall for vascular cannulas
- Renewed push for healthcare price transparency faces familiar challenges
- Survey: Tariffs expected to increase hospital costs, disrupt supply chains
- Study: Arthroplasty implants linked to metal accumulation in cerebrospinal fluid
- Novel noninvasive surgical approach shows promise in treating severe OCD
- Study: Preop mental health assessment improves postop outcomes for older patients
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement